The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

A nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians. It is the first new depression medication ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, further opening the door for dissociative and psychedelic mental ...

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical Benefits Scheme (PBS), making it more affordable for eligible patients starting from May 1. It is the first ...

The University Hospital of Tours, Tours, France, and the ANRS Emerging Infectious Diseases are set to initiate a clinical trial of a nasal spray vaccine against SARS-CoV-2, developed by the start ...